# Inhibin B/AFC Ratio for Ovarian Response

> **NCT06292806** · — · UNKNOWN · sponsor: **Insemine Humen Reproduction Centre** · enrollment: 144 (estimated)

## Conditions studied

- IVF
- Infertility, Female
- Ovulation Disorder

## Interventions

- **DRUG:** FSH-R

## Key facts

- **NCT ID:** NCT06292806
- **Lead sponsor:** Insemine Humen Reproduction Centre
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-03-20
- **Final completion:** 2025-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06292806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06292806, "Inhibin B/AFC Ratio for Ovarian Response". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06292806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*